These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34233525)

  • 21. Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
    Hoekstra AV; Ward EC; Hardt JL; Lurain JR; Singh DK; Buttin BM; Schink JC; Kim JJ
    Gynecol Oncol; 2008 Mar; 108(3):609-18. PubMed ID: 18234299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curative effects of hysteroscopic resection combined with progesterone on early-stage endometrial cancer and its prognosis.
    Kuang J; Sun S; Xu H; Ni R; Ke F
    J BUON; 2021; 26(4):1320-1326. PubMed ID: 34564987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tamoxifen, megestrol acetate, and beta interferon in endometrial cancer.
    Cardone A; Tolino A; Di Serio C; Borruto Caracciolo G; Caccavale C
    Eur J Gynaecol Oncol; 1995; 16(6):500-5. PubMed ID: 8536766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial.
    Tehranian A; Ghahghaei-Nezamabadi A; Arab M; Khalagi K; Aghajani R; Sadeghi S
    J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101863. PubMed ID: 32652300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels.
    Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia.
    Rose PG
    Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Megestrol acetate: clinical experience.
    Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
    Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study.
    Fiorica JV; Brunetto VL; Hanjani P; Lentz SS; Mannel R; Andersen W;
    Gynecol Oncol; 2004 Jan; 92(1):10-4. PubMed ID: 14751131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered claudin-4 expression in progesterone-treated endometrial adenocarcinoma cell line Ishikawa.
    Xiao-Yu P; Yan J; Cui-Ping F; Ya-Nan W; Hua L; Hua-Jun L
    Int J Gynecol Cancer; 2012 Nov; 22(9):1585-90. PubMed ID: 23095775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
    Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
    Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
    Ma AY; Xie SW; Zhou JY; Zhu Y
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
    Wang Y; Hanifi-Moghaddam P; Hanekamp EE; Kloosterboer HJ; Franken P; Veldscholte J; van Doorn HC; Ewing PC; Kim JJ; Grootegoed JA; Burger CW; Fodde R; Blok LJ
    Clin Cancer Res; 2009 Sep; 15(18):5784-93. PubMed ID: 19737954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor level as a predictor of response to megestrol acetate in advanced breast cancer: a retrospective study.
    Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Bacon LD; Rossof AH; Economou SG
    Cancer Treat Rep; 1983; 67(7-8):717-20. PubMed ID: 6871887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
    Zhuo Z; Yu H
    Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
    Kyo S; Sakaguchi J; Kiyono T; Shimizu Y; Maida Y; Mizumoto Y; Mori N; Nakamura M; Takakura M; Miyake K; Sakamoto M; Inoue M
    Clin Cancer Res; 2011 Feb; 17(3):525-37. PubMed ID: 21131554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A functional role of LEFTY during progesterone therapy for endometrial carcinoma.
    Fei W; Kijima D; Hashimoto M; Hashimura M; Oguri Y; Kajita S; Matsumoto T; Yokoi A; Saegusa M
    Cell Commun Signal; 2017 Dec; 15(1):56. PubMed ID: 29268772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Megestrol-induced clinical adrenal insufficiency.
    Goodman A; Cagliero E
    Eur J Gynaecol Oncol; 2000; 21(2):117-8. PubMed ID: 10843465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of long-term treatment with MPA on the biological character of endometrial carcinoma Ishikawa cell].
    Zhao SJ; Chen XJ; Feng YJ
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2007 Apr; 40(2):103-12. PubMed ID: 17580663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.
    Neubauer NL; Ward EC; Patel P; Lu Z; Lee I; Blok LJ; Hanifi-Moghaddam P; Schink J; Kim JJ
    Horm Cancer; 2011 Jun; 2(3):170-81. PubMed ID: 21760855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.